Feature | SCAI | February 25, 2019| Subhash Banerjee, M.D., FSCAI, Abu-Fadel Mazen, M.D., FSCAI and Rajesh Swaminathan, M.D., FSCAI

Peripheral Vascular Track Highlighted at SCAI 2019

The Society for Cardiovascular Angiography and Interventions (SCAI) 2019 Scientific Sessions in Las Vegas, May 19-22, with feature a peripheral vascular track with interactive sessions. Henry Ford Hospital CTO case.

The Society for Cardiovascular Angiography and Interventions (SCAI) 2019 Scientific Sessions in Las Vegas, May 19-22, with feature a peripheral vascular track with interactive sessions. 

The track will include a blend of clinical challenges presented by emerging interventional stars and approaches to addressing them, which will be articulated and critiqued by expert panelists. The audience will be able to participate in discussion and share their expertise and experience. The program was changed from last year to move away from global overviews toward highly specific topics that will capture the burning issues in peripheral artery disease (PAD)

Peripheral live cases will offer an opportunity to see some of the most technically refined and engaging operators demonstrate their approach to complex endovascular cases. A professionally produced broadcast will highlight each movement and device manipulation, with commentary from a group of expert panelists. 

The track also includes multiple technically enriching sessions with a mix of "do’s and don’ts," as well as ways to bail out of trouble, end of the road options, and “my worst nightmare.” Designed to foster candid discussions on the execution of specific technical maneuvers and ways to improvise out of the box solutions, these sessions will provide an opportunity to engage colleagues over the details of technical execution and device selection. 

The exhibit hall technology exhibits will offer several hands-on displays so attendees can try wires and devices. Cases over cocktails in the exhibit hall will offer immersed learning, providing an opportunity to share informal commentary, friendly critique and candid self-assessment of skills and abilities. 

The goal track will take a step beyond minimally invasive arterial interventions. These sessions have been designed to carefully choreographed synergy between devices and medical interventions as the cornerstone for delivering effective and durable therapy to patients. This concept will be front and center during highly practical didactic sessions on polyvascular disease states, pulmonary embolism, stroke interventions, venous diseases, thrombophilia, antithrombotic drug therapies and more.

Finally, the SCAI 2019 Peripheral Vascular Track has made it a priority to showcase many talented and emerging new presenters from diverse backgrounds and specialties, whose accomplishments vastly surpass their youth and experience. 

For more information: http://www.scai.org/scai2019

 

Editor's note: The authors are the program directors for the peripheral vascular track at SCAI 2019. They include: 

Subhash Banerjee, M.D., FSCAI, is a professor of medicine at the University of Texas Southwestern Medical Center (UTSW) and also is the chief of cardiology at the VA North Texas Health Care System in Dallas.

Abu-Fadel Mazen, M.D., FSCAI, is director of interventional cardiology and cardiac cath lab at the University of Oklahoma Health Sciences Center.

Rajesh Swaminathan, M.D., FSCAI, is an associate professor of medicine at Duke University School of Medicine. 

Related Content

An example of the Medis QCA angiography imaging derived fractional flow reserve (FFR) assessment. This technology removes the need for pressure wires and adenosine used in traditional FFR assessments of the coronary arteries.

An example of the Medis QCA angiography imaging derived fractional flow reserve (FFR) assessment. This technology removes the need for pressure wires and adenosine used in traditional FFR assessments of the coronary arteries.

News | Cath Lab | July 22, 2021
July 22, 2021 — Medis Medical Imaging is partnering with CORRIB Core Lab and Sinomed in randomized clinical trial of
ast End Medical announced it received U.S. Food and Drug Administration (FDA) clearance for the company's SafeCross Transseptal Radiofrequency (RF) Puncture and Steerable Balloon Introducer System. The 3-in-1 system, which includes a steerable introducer sheath with an ultra-visible positioning balloon and radiofrequency (RF) puncture dilator, aims to provide a predictable and safe solution for electrophysiology (EP) and structural heart interventions requiring left atrial access.
News | Cath Lab | July 14, 2021
July 13, 2021 — East End Medical announced it received U.S.
There is a trend in interventional cardiology that is now being called “renalism,” where patients with poor renal function are being excluded from interventional procedures because they are automatically considered too high risk. However, some hospitals are also creating cardio-renal care teams so these patients can be cared for by a team of experts rather than interventional cardiologists going it alone. #SCAI21 #SCAI2021 Creating a card0-renal program.

There is a trend in interventional cardiology that is now being called “renalism,” where patients with poor renal function are being excluded from interventional procedures because they are automatically considered too high risk. However, some hospitals are also creating cardio-renal care teams so these patients can be cared for by a team of experts rather than interventional cardiologists going it alone.

Feature | Cath Lab | May 14, 2021 | By Dave Fornell, Editor
There is a trend in interventional cardiology that is now being called “renalism,” where patients with poor renal fun
Abbott recently announced its new interventional imaging platform powered by Ultreon 1.0 Software, has gained European CE marked. This first-of-its-kind imaging software merges optical coherence tomography (OCT) intravascular imaging with the power of artificial intelligence (AI) for enhanced visualization. The new Ultreon Software can automatically detect the severity of calcium-based blockages and measure vessel diameter to enhance the precision of physicians’ decision-making during coronary stenting proc

Abbott recently announced its new interventional imaging platform powered by Ultreon 1.0 Software, has gained European CE marked. This first-of-its-kind imaging software merges optical coherence tomography (OCT) intravascular imaging with the power of artificial intelligence (AI) for enhanced visualization. The new Ultreon Software can automatically detect the severity of calcium-based blockages and measure vessel diameter to enhance the precision of physicians’ decision-making during coronary stenting procedures.

News | Cath Lab | May 12, 2021
May 12, 2021 — Abbott recently announced its new interventional imaging platform powered by Ultreon 1.0 Software, has
SCAI 2021 late-breaking presentations included the data on the Medtronic Harmony transcatheter pulmonary valve, cutting radial access hemostasis time by 50 percent, improving cardiogenic shock survival to 71 percent, and data showing very high mortality in COVID patients who suffer a STEMI heart attack. #SCAI21 #SCAI2021

SCAI 2021 late-breaking presentations included the data on the Medtronic Harmony transcatheter pulmonary valve, cutting radial access hemostasis time by 50 percent, improving cardiogenic shock survival to 71 percent, and data showing very high mortality in COVID patients who suffer a STEMI.

Feature | Cath Lab | May 06, 2021 | By Dave Fornell, Editor
April 29, 2021 — Here is the list of late-breaking study presentations and links to articles about each of them from
Most Stable Ischemic Heart Disease Patients Did Not Meet ISCHEMIA Trial Enrollment Criteria, raising questions about its application in real-world practice. #SCAI2021 Getty Images

Getty Images

News | Cath Lab | May 03, 2021
May 3, 2021 – Results from a new study find a broad range of patients who typically undergo revascularization for sta
New study demonstrates depression, HIV, mental health, obesity, alcohol and drug abuse are risk factors on most common type of heart disease in young black patients. Photo by Dave Fornell
News | Cath Lab | April 29, 2021
April 29, 2021 – A retrospective analysis of risk factors for coronary artery disease (CAD) in young African American
There are far fewer patients coming to hospitals with heart attacks during the COVID-19 pandemic as compared to averages prior to the pandemic. This has raised concerns that delayed treatment will cause an uptick in cardiac deaths and heart failure. Photo from Getty Images 

There are far fewer patients coming to hospitals with heart attacks during the COVID-19 pandemic as compared to averages prior to the pandemic. This has raised concerns that delayed treatment will cause an uptick in cardiac deaths and heart failure. Photo from Getty Images 

News | Cath Lab | April 28, 2021
April 28, 2021 – Results from a retrospective observational study, presented today at...
A cardiac cath lab at Henry Ford Hospital in Detroit. Photo by Dave Fornell

A cardiac cath lab complex PCI case at Henry Ford Hospital in Detroit. Photo by Dave Fornell

News | Cath Lab | April 28, 2021